Literature DB >> 24865619

Substance abuse treatment patients with early onset cocaine use respond as well to contingency management interventions as those with later onset cocaine use.

Lindsay M Weiss1, Nancy M Petry2.   

Abstract

Early onset drug use is associated with increased risk of developing substance use disorders, but relatively little is known about the correlates of early drug use among adults receiving treatment. A retrospective analysis of a randomized study of contingency management treatment compared cocaine-dependent patients who reported initial cocaine use at age 14 or younger (n = 41) to those who began using after age 14 (n = 387). Patients with early onset cocaine use had more legal and psychiatric problems than those who initiated cocaine use later. Patients with early-onset cocaine use also dropped out of treatment sooner and achieved less sustained abstinence than those who began using at older ages, but the interaction between age of first use and treatment condition was not significant. Early-onset cocaine use is associated with persistent psychosocial problems and an overall poor response to treatment. However, contingency management is efficacious in improving outcomes in early onset cocaine users.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cocaine; Contingency management; Early onset drug use; Outpatient treatment

Mesh:

Substances:

Year:  2014        PMID: 24865619      PMCID: PMC4074441          DOI: 10.1016/j.jsat.2014.04.003

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  39 in total

Review 1.  A meta-analysis of voucher-based reinforcement therapy for substance use disorders.

Authors:  Jennifer Plebani Lussier; Sarah H Heil; Joan A Mongeon; Gary J Badger; Stephen T Higgins
Journal:  Addiction       Date:  2006-02       Impact factor: 6.526

Review 2.  Contingency management for treatment of substance use disorders: a meta-analysis.

Authors:  Michael Prendergast; Deborah Podus; John Finney; Lisa Greenwell; John Roll
Journal:  Addiction       Date:  2006-11       Impact factor: 6.526

3.  The role of childhood risk factors in initiation of alcohol use and progression to alcohol dependence.

Authors:  Carolyn E Sartor; Michael T Lynskey; Andrew C Heath; Theodore Jacob; William True
Journal:  Addiction       Date:  2007-02       Impact factor: 6.526

4.  Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.

Authors:  Stephen T Higgins; Sarah H Heil; Robert Dantona; Robert Donham; Martha Matthews; Gary J Badger
Journal:  Addiction       Date:  2007-02       Impact factor: 6.526

5.  A prospective study of the effects of age of initiation of alcohol and drug use on young adult substance dependence.

Authors:  Kevin M King; Laurie Chassin
Journal:  J Stud Alcohol Drugs       Date:  2007-03       Impact factor: 2.582

6.  Age at drinking onset and alcohol dependence: age at onset, duration, and severity.

Authors:  Ralph W Hingson; Timothy Heeren; Michael R Winter
Journal:  Arch Pediatr Adolesc Med       Date:  2006-07

7.  Early initiation of substance use and subsequent risk factors related to suicide among urban high school students.

Authors:  Hyunsan Cho; Denise Dion Hallfors; Bonita J Iritani
Journal:  Addict Behav       Date:  2007-01-08       Impact factor: 3.913

8.  Predictive validity of the Addiction Severity Index's composite scores in the assessment of 2-year outcomes in a methadone maintenance population.

Authors:  G B Bovasso; A I Alterman; J S Cacciola; T G Cook
Journal:  Psychol Addict Behav       Date:  2001-09

9.  Effectiveness of abstinence-based incentives: interaction with intake stimulant test results.

Authors:  Maxine L Stitzer; Nancy Petry; Jessica Peirce; Kimberly Kirby; Therese Killeen; John Roll; John Hamilton; Patricia Q Stabile; Robert Sterling; Chanda Brown; Ken Kolodner; Rui Li
Journal:  J Consult Clin Psychol       Date:  2007-10

10.  Sex, age, and progression of drug use in adolescents admitted for substance use disorder treatment in the northeastern United States: comparison with a national survey.

Authors:  Bethany K Bracken; John Rodolico; Kevin P Hill
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

View more
  6 in total

1.  Using contingency management procedures to reduce at-risk drinking in heavy drinkers.

Authors:  Donald M Dougherty; Sarah L Lake; Nathalie Hill-Kapturczak; Yuanyuan Liang; Tara E Karns; Jillian Mullen; John D Roache
Journal:  Alcohol Clin Exp Res       Date:  2015-04       Impact factor: 3.455

2.  Illicit drug use in acute care settings.

Authors:  Harjot Kaur Grewal; Lianping Ti; Kanna Hayashi; Sabina Dobrer; Evan Wood; Thomas Kerr
Journal:  Drug Alcohol Rev       Date:  2015-05-06

3.  Interest and preferences for contingency management design among addiction treatment clientele.

Authors:  Bryan Hartzler; Sharon Garrett
Journal:  Am J Drug Alcohol Abuse       Date:  2015-12-08       Impact factor: 3.829

4.  Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy.

Authors:  Shannon M Nugent; Bobbi Jo Yarborough; Ning X Smith; Steven K Dobscha; Richard A Deyo; Carla A Green; Benjamin J Morasco
Journal:  Gen Hosp Psychiatry       Date:  2017-11-08       Impact factor: 3.238

Review 5.  Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence.

Authors:  Kenneth M Dürsteler; Eva-Maria Berger; Johannes Strasser; Carlo Caflisch; Jochen Mutschler; Marcus Herdener; Marc Vogel
Journal:  Subst Abuse Rehabil       Date:  2015-06-17

6.  Exploring associations between early substance use and longitudinal socio-occupational functioning in young people engaged in a mental health service.

Authors:  Jacob J Crouse; Kate M Chitty; Frank Iorfino; Django White; Alissa Nichles; Natalia Zmicerevska; Adam J Guastella; Ahmed A Moustafa; Daniel F Hermens; Elizabeth M Scott; Ian B Hickie
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.